Home > Insider Trading > Filing (0001935979-25-000018)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1935979	Biohaven Ltd.	BHVN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1027035	W John Childs	C/O Biohaven Ltd. 215 Church Street New Haven CT 06510		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2025-03-04	25,000	$30.39	2,320,571	No	4	P	Indirect	By John W Childs 2013 Revocable Trust
Common Shares	Acquisiton	2025-03-04	3,400	$30.73	24,452	No	4	P	Indirect	By 2007 Charitable Remainder Trust
Common Shares	Acquisiton	2025-03-04	3,400	$30.73	76,570	No	4	P	Indirect	By 2013 Charitable Remainder Trust
Common Shares	Acquisiton	2025-03-04	900	$30.73	25,291	No	4	P	Indirect	By 1994 Charitable Remainder Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By John W Childs 2013 Revocable Trust
No	4	P	Indirect	By 2007 Charitable Remainder Trust
No	4	P	Indirect	By 2013 Charitable Remainder Trust
No	4	P	Indirect	By 1994 Charitable Remainder Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	4,096,512	Indirect	By 2021 B-H Charitable Remainder Trust

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.17 - $30.48, inclusive. The Reporting Person undertakesto provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at eachseparate price within the ranges set forth in this footnote to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.54 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.